Trade Summary

1 week ago, Boudreau Philip P, serving as EVP, CFO at Abbott Laboratories (ABT), purchased 2,200 shares at $91.50 per share, for a total transaction value of $201,300.00. Following this transaction, Boudreau Philip P now holds 82,648 shares of ABT.

This purchase represents a 3.00% increase in Boudreau Philip P's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 23, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 27, 2026, 4 days after the trade was made.

Abbott Laboratories operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.